Cite
HARVARD Citation
Cao, Z. et al. (2020). Is Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis. BioMed research international. p. . [Online].